title: Genetic reduction of insulin-like growth factor-1 mimics the anticancer effects of calorie restriction on cyclooxygenase-2-driven pancreatic neoplasia.
abstract: Risk of pancreatic cancer, the fourth deadliest cancer in the United States, is increased by obesity. Calorie restriction (CR) prevents obesity, suppresses carcinogenesis in many models, and reduces serum levels of IGF-1. In the present study, we examined the impact of CR on a model of inflammation-associated pancreatitis and pancreatic dysplasia, with a focus on the mechanistic contribution of systemic IGF-1. Administration of a 30% CR diet for 14 weeks decreased serum IGF-1 levels and hindered pancreatic ductal lesion formation and dysplastic severity, relative to a higher calorie control diet, in transgenic mice overexpressing COX-2 [bovine keratin-5 promoter (BK5.COX-2)]. These findings in CR mice correlated with reductions in Ki-67-positive cells, vascular luminal size, VEGF expression, and phosphorylation and total expression of downstream mediators of the IGF-1 pathway. Cell lines derived from BK5.COX-2 ductal lesions (JC101 cells) formed pancreatic tumors in wild-type FVB mice that were significantly reduced in size by a 14-week CR regimen, relative to the control diet. To further understand the impact of circulating levels of IGF-1 on tumor growth in this model, we orthotopically injected JC101 cells into liver-specific IGF-1-deficient (LID) mice. The approximate 65% reduction of serum IGF-1 levels in LID mice resulted in significantly decreased burden of JC101 tumors, despite modestly elevated levels of circulating insulin and leptin. These data show that CR prevents development of dysplasia and growth of pancreatic cancer through alterations in IGF-1, suggesting that modulation of this pathway with dietary and/or pharmacologic interventions is a promising pancreatic cancer prevention strategy.
authors: Department of Molecular Carcinogenesis, University of Texas MD Anderson Cancer Center, Smithville, Texas, USA.
authors: Laura M
authors: LM
authors: Lashinger
authors: Lauren M
authors: LM
authors: Malone
authors: Mark J
authors: MJ
authors: McArthur
authors: Jason A
authors: JA
authors: Goldberg
authors: Elizabeth A
authors: EA
authors: Daniels
authors: Amy
authors: A
authors: Pavone
authors: Jennifer K
authors: JK
authors: Colby
authors: Nicole C
authors: NC
authors: Smith
authors: Susan N
authors: SN
authors: Perkins
authors: Susan M
authors: SM
authors: Fischer
authors: Stephen D
authors: SD
authors: Hursting
references: Int J Exp Pathol. 2002 Oct;83(5):239-45
references: 12641820
references: Cancer. 2001 Jan 15;91(2):333-8
references: 11180079
references: Am J Pathol. 2003 Sep;163(3):1001-11
references: 12937141
references: Int J Cancer. 2006 May 1;118(9):2337-43
references: 16331623
references: Nat Rev Cancer. 2004 Aug;4(8):579-91
references: 15286738
references: Gastroenterology. 2009 Aug;137(2):482-8
references: 19375425
references: Cancer Res. 1999 Mar 1;59(5):987-90
references: 10070951
references: Cell. 1994 Dec 16;79(6):927-30
references: 8001140
references: Cancer Res. 2001 Mar 1;61(5):1833-8
references: 11280733
references: Eur J Cancer. 2008 Jul;44(11):1577-86
references: 18445520
references: Annu Rev Med. 2003;54:131-52
references: 12525670
references: Cancer Res. 2003 Aug 1;63(15):4384-8
references: 12907608
references: Mol Carcinog. 2009 Dec;48(12):1071-6
references: 19760669
references: Gastroenterology. 2007 May;132(6):2208-25
references: 17498513
references: Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7324-9
references: 10377413
references: Science. 2009 Jul 10;325(5937):201-4
references: 19590001
references: Cancer Res. 2002 Feb 15;62(4):1030-5
references: 11861378
references: J Cell Physiol. 1995 Oct;165(1):155-63
references: 7559796
references: Oncogene. 2001 Dec 13;20(57):8203-14
references: 11781836
references: Cancer Lett. 2003 Jun 10;195(2):127-37
references: 12767520
references: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references: 19474385
references: Arch Physiol Biochem. 2008 Feb;114(1):71-83
references: 18465361
references: Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12890-5
references: 17652168
references: Cancer Res. 1993 Jan 1;53(1):46-52
references: 8416749
references: Gastroenterology. 2001 Apr;120(5):1263-70
references: 11266389
references: J Clin Pathol. 2004 Jun;57(6):630-6
references: 15166270
references: Mol Cancer Ther. 2008 Sep;7(9):2575-88
references: 18790742
references: Physiol Rev. 1990 Jul;70(3):591-614
references: 1694588
references: Curr Cancer Drug Targets. 2007 Aug;7(5):484-91
references: 17691908
references: Ann N Y Acad Sci. 1999 Jun 30;880:201-9
references: 10415865
references: Cancer Res. 1995 May 15;55(10):2007-11
references: 7743492
references: N Engl J Med. 1993 May 20;328(20):1433-7
references: 8479461
references: Cancer Res. 1995 Jun 1;55(11):2463-9
references: 7758000
references: Curr Biol. 2001 Jan 9;11(1):R25-7
references: 11166192
references: Pancreatology. 2006;6(4):279-85
references: 16636600
references: Cancer Res. 2008 May 15;68(10):3680-8
references: 18483250
references: CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
references: 20610543
references: Cancer Res. 1998 Aug 1;58(15):3353-61
references: 9699666
references: Neoplasia. 2008 Aug;10(8):782-96
references: 18670639
references: Cancer Res. 1997 Nov 1;57(21):4667-72
references: 9354418
references: Diabetes. 2001 May;50(5):1110-8
references: 11334415
references: Int J Cancer. 2004 Jul 1;110(4):584-8
references: 15122592
references: Oncogene. 2009 Aug 27;28(34):3009-21
references: 19581933
references: Pancreatology. 2006;6(3):206-9
references: 16549939
references: Mol Cancer Ther. 2009 May;8(5):1095-105
references: 19366899
references: Cancer Res. 1981 Mar;41(3):888-93
references: 7459874
references: N Engl J Med. 2003 Apr 24;348(17):1625-38
references: 12711737
references: Cancer Res. 2001 Jan 15;61(2):589-93
references: 11212254
references: Carcinogenesis. 1997 Nov;18(11):2107-11
references: 9395209
references: Physiol Genomics. 2005 Nov 17;23(3):343-50
references: 16189280